Plastic and Reconstructive Surgery • June 2018 release. For example, a higher volume surgeon might be better prepared to handle anatomical variations, extensive fibrosis, or other challenging situations. In addition, incomplete transection of the transverse carpal ligament is a relatively common reason for unrelieved symptoms following carpal tunnel release, 10, 11 which might be less likely to occur in more experienced surgeons.
Conversely, despite the specific challenges of carpal tunnel release, it has been suggested that trained nurse practitioners might be able to perform carpal tunnel release with the same results on patient outcome as achieved by surgeons. 12, 13 A reported argument for having a nurse practitioner operate is reduction in waiting time for carpal tunnel release. 12, 13 This suggests that the operator's education is not considered a predictor for outcome after carpal tunnel release. A recent study assessed the effects of hand fellowship training on rates of complications for both endoscopic and open carpal tunnel release.
14 Neither operative technique nor type of fellowship training (hand fellowship training versus non-hand fellowship training) had a statistically significant impact on overall complication rates, suggesting that for carpal tunnel release specifically there is no association between surgeon training and complication rate. However, these results were not adjusted for potential confounding factors or for baseline measurements. Fellows were possibly less likely to treat complicated cases (e.g., patients with comorbidities or more severe symptoms) compared with more-senior hand surgeons. Furthermore, it has not been assessed whether, within the surgeon population, there is an association between surgeon experience and patient outcome. Therefore, the aim of this study was to assess whether there is an association between annual surgeon volume and patient outcomes at 6 months postoperatively after open carpal tunnel release.
PATIENTS AND METHODS

Data Collection
All patients with carpal tunnel syndrome who underwent carpal tunnel release between 2011 and 2015 at one of the 11 specialized outpatient hand surgery clinics (Xpert Clinic) in The Netherlands were eligible for the study. As part of routine clinical care, patients were included in a large multicenter web-based database, which contains patient-rated outcome measures. All patients signed informed consent and the study was approved by our local ethics committee. Patients who underwent a primary carpal tunnel release and had at least a baseline measurement and one follow-up measurement on the Boston Carpal Tunnel Questionnaire were included in the study. Patients where an operative report was not available or the surgeon could not be identified were excluded. In addition, patients operated by a surgeon who performed carpal tunnel releases for less than 1 year in our cohort were also excluded.
Covariates of Interest
The following study data were abstracted from the database, because they are known prognostic factors for clinical outcome following carpal tunnel release identified based on literature review [15] [16] [17] [18] [19] [20] : age, sex, smoking status, alcohol use, and comorbidities (i.e., rheumatoid arthritis, diabetes mellitus, peripheral neuropathy, cervical radiculopathy, trigger fingers, tendinitis, radiocarpal arthritis, carpometacarpal joint arthritis, scaphotrapeziotrapezoidal joint arthritis, history of trauma of the wrist, Dupuytren's disease, cubital tunnel syndrome, ulnocarpal impingement, radial tunnel syndrome, and Wartenberg syndrome). For the analysis, cubital tunnel syndrome, radial tunnel syndrome, Wartenberg syndrome, and pronator syndrome were grouped under "other nerve compressions." In addition, a group "other comorbidities" was defined, including the following comorbidities: scaphotrapeziotrapezoidal joint arthritis, radiocarpal arthritis, peripheral neuropathy, cervical radiculopathy, and ulnocarpal impingement. Concomitant procedures (i.e., procedures carried out at the same time as the carpal tunnel releases) were scored as well.
Outcome Measures
Our primary outcome measure was the Boston Carpal Tunnel Questionnaire score at 6 months postoperatively. The scores at intake were also abstracted, to be able to adjust for score at intake. In addition, to illustrate the course of the outcomes on the Boston Carpal Tunnel Questionnaire, measurements at 6 weeks and 3 months postoperatively were collected as well. Two domains of the Boston Carpal Tunnel Questionnaire were assessed: the Symptom Severity Scale and the Functional Status Scale. The Symptom Severity Scale and Functional Status Scale consist of 11 and eight items, respectively. All items of both scales have five response categories ranging from 1 to 5, and a higher score represents worse symptoms/lower level of function. Responses to items were averaged to create an overall score for each domain. 21 The secondary outcome measure was overall pain assessed using the visual analogue scale, ranging from 0 to 100, 6 months postoperatively. Higher score represents greater pain intensity. The visual analogue scale was performed at intake and 6 weeks, 3 months, and 6 months postoperatively. In addition, adverse events were scored, including infections treated with antibiotics, wound dehiscence, postoperative bleeding, and neuroma of the median nerve. We scored only adverse effects related directly to the carpal tunnel release. Information on the presence of adverse events was abstracted from the medical charts (S.E. and M.C.J.).
Main Exposure Variable: Annual Surgeon Volume
Surgeon volume was defined as all carpal tunnel releases, including reoperation and concomitant interventions, performed by the participating surgeon, divided by the number of years the surgeon performed carpal tunnel releases during the study period. Similar definitions of annual surgeon volume have been described previously. 1, 7, 22 All procedures were performed by European board-certified hand surgeons or surgeons following a hand fellowship.
Procedure
All patients underwent an open carpal tunnel release. Neither endoscopic procedures nor modifications were performed. In general, the following protocol was used in all treatment centers within the Xpert Clinic group, with only minor variations between surgeons: longitudinal incision was placed through the subcutaneous fat and palmar fascia until the Guyon canal. Fibers were revealed in the radial-ward direction and the transverse carpal ligament was divided. The median nerve was separated from the roof of the carpal tunnel in the proximal direction using scissors, where potential transverse fibers could be dissected. Subsequently, the tendons and median nerve were inspected. When hemostasis was obtained, the fat was repositioned and the skin sutured with 4-0 Prolene (Ethicon, Inc., Somerville, N.J.). Sterile dressing and compression bandage was applied. All patients received standard postoperative care and hand therapy by a hand therapist consisting of nerve and tendon-gliding exercises.
Statistical Analysis
Parametric data were presented as mean and standard deviation and nonparametric data as median and interquartile range. We categorized the variable "annual surgeon volume" for presentation purposes, using tertile-derived categories, into three subgroups: low-volume, mediumvolume, and high-volume surgeons. Given the number of missing values, a nonresponder analysis at 6 months postoperatively for baseline variables was performed using chi-square statistics and unpaired t tests. Based on this analysis, we concluded that missing data could be classified as "missing completely at random." Therefore, we used multiple imputation to impute the missing values. 23 Ten versions of the data set were produced and independently analyzed, each with its own set of imputed values. To give a single mean estimate, the pooled estimates of 10 imputed data sets were used as statistical results.
Because of the hierarchical structure of the data (level 1 = patients; level 2 = surgeons), multilevel random intercept linear regression analyses were performed to assess whether there was an association between surgeon annual volume and outcome measurements. First, we ran an intercept-only model to assess whether there was a significant difference in patient outcome across surgeons, regardless of surgeon volume. In addition, we calculated the intraclass correlation coefficient to assess the overall variability in patient outcomes between surgeons. An intraclass correlation coefficient close to 0 would suggest no substantial variability between surgeons in patient outcomes. To adjust the estimated effect of surgeon volume for known prognostic factors identified based on literature review, the variables age, sex, smoking status, alcohol use, comorbidities, concomitant procedures, and intake score for the respective questionnaire were included in the model as fixed factors. Values of p < 0.05 were considered statistically significant. Analyses were performed using IBM SPSS Version 21 (IBM Corp., Armonk, N.Y.).
RESULTS
A total of 2057 patients who underwent carpal tunnel release within the specified time window were identified. After exclusions, 1345 patients were eligible for this study (Fig. 1) , operated on by 17 surgeons: 16 hand surgeons and one surgeon in hand fellowship training. The annual surgeon volume ranged from six to 163 procedures per year, with a median volume of 75 procedures (interquartile range, 50 to 149 procedures) (Fig. 2) . Some of the variables had missing values because of nonresponse. Regarding the baseline variables, there were missing values for smoking status (35 percent missing) and alcohol use (35 percent missing). The Plastic and Reconstructive Surgery • June 2018 proportion of missing data for all other baseline variables ranged from 0 to 1 percent. Regarding the outcome measures, there were nonresponse rates of 0, 52, 13, and 27 percent for both the Symptom Severity Score and the Functional Status Score at baseline, 6 weeks, 3 months, and 6 months postoperatively, respectively. These were 3, 9, 15, and 28 percent for the visual analogue scale score. Because adverse events were reported in only 23 cases (1.6 percent), we did not use this variable as an outcome measure. Adverse events included wound infection in 18 cases and wound dehiscence in five cases. There were a total of 212 concomitant procedures. Table 1 shows the demographic, clinical, and procedural characteristics of the cohort. Figures 3 and 4 illustrate the course of the outcome measures, from intake to 6 months postoperatively, grouped by whether the surgeon was a low-, medium-, or high-volume surgeon for this procedure. The boundaries for the low-, medium-, and high-volume groups were 6 to 44, 47 to 71, and 75 to 163 operations annually, and there were 171, 459, and 715 patients in the low-, medium-, and high-volume groups, respectively. The low-, medium-, and high-volume groups included six, six, and five surgeons, respectively.
The intraclass correlation coefficients (Symptom Severity Scale, ρ = 0.005; Functional Status Scale, ρ = 0.006; and visual analogue scale, ρ = 0.002) indicated that, respectively, only 0.5, 0.6, and 0.2 percent of the patient outcome variance on the Symptom Severity Scale, Functional Status Scale, and visual analogue scale 6 months postoperatively could be explained by random differences between surgeons. Unadjusted and adjusted models for the association between annual surgeon volume and patient outcome on the Boston Carpal Tunnel Questionnaire (Symptom Severity Scale and Functional Status Scale domains) and visual analogue scale overall pain indicated no significant association between annual surgeon volume and patient outcome 6 months postoperatively for any of the outcome measures ( Table 2 ). To assess whether the patient outcomes of the surgeon following a fellowship influenced the overall results, we also ran the analysis on the data set including board-certified hand surgeons only. The results remained unchanged.
DISCUSSION
This study, based on a large cohort and including highly specialized surgeons only, did not show an association between annual surgeon volume and patient outcome after an open carpal tunnel release assessed using the Boston Carpal Tunnel Questionnaire and the visual analogue scale. In addition, we found that only 0.6 percent of the variance on the Boston Carpal Tunnel Questionnaire 6 months postoperatively could be explained by random differences between surgeons, regardless of surgeon volume.
Previous studies have shown an association between surgeon volume and patient outcome, suggesting that centralization of some types of surgery in a small number of centers is beneficial. 2, 22 In hand surgery specifically, it is unknown whether there is an association between surgeon volume and patient outcome. It could be argued that surgeon experience might mainly be beneficial in technical challenging procedures, but data are lacking both for more challenging, more complex procedures and for more simple procedures in hand surgery. BMI, body mass index; CMC1, first metacarpophalangeal; CTR, carpal tunnel release. *Refers to scaphotrapeziotrapezoidal joint arthritis, radiocarpal arthritis, peripheral neuropathy, cervical radiculopathy, and ulnocarpal impingement.
Plastic and Reconstructive Surgery • June 2018 The overall improvement in functional status and symptom severity found in our study is in line with the literature. 24 Katz et al. described patient outcomes after open carpal tunnel release carried out by 26 surgeons in different offices in Maine, 24 with symptom severity and functional status 6 months postoperatively similar to our results despite symptom severity and functional status at intake being slightly higher at baseline compared with our cohort. Mack et al. reported patient outcomes at 3 months after open carpal tunnel release on 134 patients 25 and found a slightly larger change from baseline compared with our results. The total number of reported adverse events was slightly higher compared with our results, with wound dehiscence occurring in 4 percent and infection in less than 1 percent of cases compared with 0.4 and 1.3 percent, respectively, in our study. Smetana et al. reported a similar incidence of wound dehiscence of 1.2 percent and median nerve palsy or injury in 0.22 percent of 28,086 cases of isolated open carpal tunnel release, and infection rate was not reported. 14 The main strength of our study is the size of the study population and the detailed outcome assessment, compared with many studies focusing only on symptom or pain reduction. 26 We were able to test our hypothesis on a relatively large database because of the unique registration system on clinical outcomes that Xpert Clinic uses. This leads to very small confidence intervals in the main analysis, where clearly trends indicating a volume effect are lacking. Several limitations of our study should, however, also be considered. The major limitation of our study is the surgeon cohort in which all the procedures were performed (i.e., the cohort of surgeons are highly specialized and the procedures were carried out in highly specialized centers). In contrast, there was still a wide range (six to 163) in the number of carpal tunnel releases performed by each of the participating surgeons. In addition, it has been recognized that endoscopic carpal tunnel release has a steep learning curve. [27] [28] [29] Considering the complexity of this procedure compared with open carpal tunnel release, 30 the learning curve for open carpal tunnel release might flatten out at a relatively early stage that had already been passed by the surgeons in our cohort. Furthermore, because all of the procedures were performed within one group of uniformly organized clinics with a similar patient population, we could not account for a potential hospital volume-outcome relation. Previous studies have shown an association between hospital volume and patient outcome beyond the surgeon's experience; the relation between the number of patients undergoing a specific operation at a specific hospital and their postsurgical outcomes indicates that larger volume hospitals yield better patient outcomes, despite individual surgeon volume.
3,31
CONCLUSIONS
Our study shows that specialized hand surgeons have similar patient outcomes following open carpal tunnel release, and their annual volume does not influence patient outcome. However, whether our results apply to orthopedic surgeons, neurosurgeons, and plastic surgeons in general and, for example, to residents and nurse practitioners still has to be investigated in further studies. BCTQ, Boston Carpal Tunnel Questionnaire; SSS, Symptom Severity Scale; FSS, Functional Status Scale; VAS, visual analogue scale. *Symptom Severity Scale, Functional Status Scale, and visual analogue scale for overall pain. †Univariable analysis for the association between annual surgeon volume and patient outcome. ‡Adjusted for score at intake for respective questionnaire, age, sex, smoking status, alcohol use, concomitant procedure, and comorbidities (diabetes mellitus, rheumatoid arthritis, first carpometacarpal joint arthritis, Dupuytren's disease, trigger fingers, tendinitis, history of trauma of the wrist, compression neuropathy, and the other comorbidity).
